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Surgical creation of new anastomosis has been proposed as
the preferred treatment for perianastomotic stenoses of
fistulae. However, disadvantages of surgical approach have
included (1) frequent conversion of fistula to a graft by using
synthetic graft material to create a new anastomosis,
(2) shortening the length of the cannulation segment by
proximal autologous arteriovenous neoanastomosis, and
(3) abandoning the fistula altogether in favor of a synthetic
graft. We report the results of a prospective study using
percutaneous balloon angioplasty (PTA) to treat fistulae with
perianastomotic lesions. Seventy-three consecutive patients
undergoing 112 PTA procedures for the treatment of
perianastomotic lesions were studied. Primary and secondary
patency rates were calculated. Procedure success,
procedure-related complications, and conversion of fistulae
to grafts were recorded. The initial success rate was 97%.
The degree of stenosis before and after PTA was 8179 and
11711%, respectively. Primary patency rates at 6, 12, and 18
months were 75, 51, and 41%, respectively. Secondary
patency rates at 6, 12, and 18 months were 94, 90, and 90%,
respectively. Grade I hematoma occurred in three and vein
rupture in two cases. No grafts were inserted. These
outcomes are superior to those that have been reported for
surgery. The outpatient PTA is safe and effective for the
management of perianastomotic stenosis. Because of its
advantage of fistula preservation, the percutaneous
approach should be considered as the preferred first-line
therapy for the management of perianastomotic fistula
lesions.
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Surgery has been proposed as the preferred treatment over
the percutaneous approach for the management of perianas-
tomotic lesions associated with arteriovenous fistulae (AVF)
created for hemodialysis. However, this approach is sup-
ported by only a small number of studies.1–5 In addition, the
presence of multiple confounders in these reports such as the
inclusion of small number of patients with stenosis in the
anastomotic region, a retrospective study design, limited
availability of demographic characteristics of study patients,
and variable definitions of patency rates does not allow a firm
conclusion in favor of surgery.1–5 An issue of particular
concern in these studies is the frequent surgical insertion of
synthetic material to repair the fistula with consequent
conversion of a fistula to an arteriovenous graft and thereby
introducing all of the complications (stenosis, thrombosis,
and infection) commonly associated with this type of device.
In addition, the surgical approach can result in limitation of
the fistula segment available for cannulation and abandon-
ment of fistulae with early failure in favor of graft insertion.1,5
This is a report of a prospective analysis of the per-
cutaneous approach to the treatment of perianastomotic
stenosis in AVF cases.
RESULTS
Demographic characteristics of the study patients revealed
that 72% of patients were males with a mean age of 52.679.3
years (range 23–70) (Table 1). African Americans and
Hispanics comprised 85% of the study population and
hypertension was the cause of end-stage renal disease in over
half of the patients.
One hundred and twelve consecutive procedures were
performed in 73 patients. The location of stenotic lesions in
all procedures is shown in Table 2. Juxta-anastomotic stenosis
was the most common lesion observed, occurring in 98 cases,
as the only stenosis in 76 cases, and in combination with
anastomotic and/or arterial stenosis in 22 cases. Arterial
anastomosis stenosis was documented in 32 cases, in
combination with juxta-anastomotic and/or arterial lesions
in 22 cases. In addition, 39 cases demonstrated stenosis above
the juxta-anastomotic region (proximal venous only¼ 30,
central venous only¼ 5, and both proximal and central¼ 4).
Overall, 49 cases (44%) with stenosis in the perianastomotic
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area demonstrated coexisting lesions elsewhere in the access
circuit (feeding artery proximal to the anastomosis¼ 10 and
stenosis on the venous side¼ 39).
Percutaneous balloon angioplasty was attempted in all 112
cases, with an initial success rate of 97%. This procedure was
not successful in three cases. The degree of stenosis before
angioplasty was 8179%. After angioplasty, the residual
stenosis was found to be 11711%. Primary patency rates at
6, 12, and 18 months were 75, 51, and 41%, respectively
(Figure 1). Secondary patency rates at 6, 12, and 18 months
were 94, 90, and 90%, respectively.
There were 41 patients with forearm (radiocephalic¼ 38
and radiobasilic¼ 4) and 32 with upper arm fistulae who
underwent 63 and 49 procedures, respectively. There was no
statistical difference in the number of procedures in each
category. Comparison of primary patency rates between these
two groups suggested a trend to higher patency rates in upper
arm fistulae (P40.05). Compared to forearm fistulae,
primary patency rates in upper arm fistulae were 77 vs
70% at 6 months, 52 vs 47% at 12 months, and 52 vs 35% at
18 months (Figure 2).
Patency analysis based on the status of the AVF revealed
that there were 41 patients with early AVF failure (fore-
arm¼ 23 and upper arm¼ 18) and 32 patients with mature
fistula dysfunction (forearm¼ 18 and upper arm¼ 14).
Fistulae with early failure underwent 69 procedures,whereas
mature fistulae had 43 procedures. Overall, patients with
early failure received 1.770.1 procedures, whereas mature
fistulae had 1.470.1 procedures (P¼ 0.04). Compared to
mature fistulae, primary patency rates were significantly
lower in fistulae with early failure (P¼ 0.027): 59 vs 89% at 6
months, 46 vs 59% at 12 months, and 25 vs 56% at 18
months (Figure 3). Secondary patency rates revealed no
significant differences for fistulae with early failure vs mature
fistulae: 94 vs 95% at 6 months and 94 vs 93% at 12 and 18
months. Median primary patency was 24 months for mature
fistulae; for fistulae with early failure, median primary
patency was 11 months (P¼ 0.018).
Table 1 | Demographic characteristics of the study patients
Number of patients 73
Age (years) 52.679.3
Gender
Men (%) 72%
Race/ethnicity
African American 39 (53%)
Hispanic 23 (32%)
Haitian 6 (8%)
Caucasian 5 (7%)
Cause of ESRD
Hypertension 41 (56%)
Diabetic nephropathy 23 (32%)
Glomerulonephritis 2 (3%)
Polycystic kidney disease 2 (3%)
Lupus nephritis 2 (3%)
HIV-associated nephropathy 1 (1%)
Obstructive uropathy 1 (1%)
Chemotherapy 1 (1%)
Type of fistula
Forearm 41 (56%)
Upper arm 32 (44%)
ESRD, end-stage renal disease.
Data are mean7s.d.
Table 2 | Location of stenoses in all 112 procedures
Type of stenosis Number
Juxta-anastomotic stenosis 98
JAS only 76
JAS+arterial anastomosis 16
JAS+arterial anastomosis+arterial stenosis* 2
JAS+arterial stenosis* 4
Arterial anastomotic stenosis 32
Arterial anastomosis only 10
Arterial anastomosis+arterial stenosis* 4
Coexisting stenosis on the venous side 39
Proximal stenosis only 30
Central stenosis only 5
Proximal+central stenosis 4
JAS, juxta-anastomotic stenosis.
In 10 cases of perianastomotic lesions (*2+4+4), a coexisting stenosis was found in
the artery upstream from the anastomosis. Likewise, in 39, cases a coexisting lesion
was seen on the venous side in patients with perianastomotic stenosis.
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Figure 1 | Primary and secondary patency following percuta-
neous balloon angioplasty of perianastomotic AVF stenosis.
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Figure 2 | Comparison of primary patency between forearm and
upper arm fistulae.
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There were 29 patients who underwent repeat procedures
and were included in the life table analysis. A total of 68
procedures were performed in this cohort. The demographic
characteristics of this group demonstrated that 69% (20/29)
of the patients who required repeat intervention had early
AVF failure (Table 3). In contrast, there were only nine
patients with mature fistulae that needed a repeat interven-
tion. The demographic characteristics also revealed that there
were no significant differences regarding age, race, gender,
and the cause of end-stage renal disease between patients
with early failure requiring repeat procedures and those with
mature AVF needing repeat procedures.
Both pre- and postangioplasty flow studies were available
in 60 of the 68 cases of mature fistulae. In these patients,
postangioplasty flow showed a mean of 10097347 ml/min
compared to a pretreatment value of 5247189 ml/min.
Blood flow failed to increase by more than 20% in seven cases
(preangioplasty¼ 6327179 ml/min and postangioplas-
ty¼ 6797181 ml/min). Five were forearm and two were
upper arm fistulae. Access flow was available in 38/41 patients
with early AVF failure. In this group, postangioplasty access
flow was 9697394 ml/min. Preprocedure flow was not
available in these cases because none of the patients in this
cohort had started dialysis.
In this study, there were five complications (4.4%): three
minor (2.6%) and two major (1.7%). Minor complications
included one minor extravasation of radiocontrast and two
patients with a grade I hematoma that did not need any
specific intervention. The two major complications were both
vein rupture that required prolonged inflation of the
angioplasty balloon to stop an expanding hematoma. These
two patients developed fistula thrombosis. In one patient,
this occurred during the first procedure when vein rupture
occurred and the access thrombosed. In the other, it resulted
during a repeat procedure at 4 months owing to vein rupture.
Both these patients lost their access. The three initial failures
were owing to the inability to navigate the guidewire across
the arterial anastomosis and into the proximal radial artery.
These patients, all having a radiocephalic fistula, were
referred to vascular surgery for the creation of a loop fistula
using the same cephalic vein. Two received a loop fistula
successfully, whereas the third patient refused further access
surgery, and became catheter consigned.
Of note, none of the patients in this study were converted
to an arteriovenous graft and 68/73 (93%) are functional
with a mean follow-up of 1277.4 months.
DISCUSSION
The autologous AVF is the preferred form of hemodialysis
access because of its superior longevity as well as lower
complication rates. However, even this type of access does
experience complication such as venous stenosis. Recent data
have emphasized that the lesions in the perianastomotic
region are more common (B40%) than previously re-
ported.6,7 In fact, these are the predominant stenoses in
fistulae with early failure.7 Previously, surgical creation of a
new anastomosis has been highlighted to be the preferred
approach for the management of these lesions.1–5 However,
the findings of the current study suggest that these stenoses
can be safely and successfully managed percutaneously, an
approach that offers advantages over surgery.
The surgical approach for the management of stenosis in
the arterial anastomotic region has been supported by only a
few reports.1–5 Importantly, not all of the patients in these
Table 3 | Demographic characteristics of patients undergoing
repeat interventions
Number of patients 29
Age (years) 5478
Gender
Men (%) 66%
Race/ethnicity
African American 14 (48%)
Hispanic 10 (35%)
Haitian 3 (10%)
Caucasian 2 (7%)
Cause of ESRD
Hypertension 16 (55%)
Diabetic nephropathy 11 (38%)
Glomerulonephritis 1 (3.5%)
Lupus nephritis 1 (3.5%)
Type of fistula
Forearm 17 (59%)
Upper arm 12 (41%)
Status of fistula
Early failure 20 (69%)
Mature fistula 9 (31%)
ESRD, end-stage renal disease.
Data are mean7s.d.
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Figure 3 | Comparison of primary patency between mature and
fistulae with early failure. Secondary patency rates revealed no
significant differences for fistulae with early failure vs mature fistulae:
94 vs 95% at 6 months and 94 vs 93% at 12 and 18 months.
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studies demonstrated perianastomotic lesions. Additionally,
these studies have clearly used synthetic material to treat
anastomotic stenosis, thereby converting AVF to grafts. Only
one study was both prospective and controlled (Tessitore N,
Lipari G, Poli A et al. J Am Soc Nephrol 2004; 15: 202A). The
others were all retrospective and a majority limited by a small
sample size ranging from 14 to 29 patients.
In contrast to the surgical reports, all 112 cases treated
with PTA in the current study had stenosis in the arterial
anastomotic region. Of note, none of the patients received an
arteriovenous graft, whereas the surgical approach has
documented placement of synthetic material in as many as
39–54% of the patients5 (Tessitore N, Lipari G, Poli A et al.
J Am Soc Nephrol 2004; 15: 202A). The cannulation area was
preserved in all of the patients treated in the present study,
whereas reduction in this segment has been a concern with
the surgical approach.1,4,5 Because surgical reports also
included patients with stenoses in locations other than the
perianastomotic area, used a variable definition of patency
rates, or excluded patients with early fistula failure, the
comparison of patency rates of these studies with the
percutaneous management must be performed with cau-
tion1,2,4,5 (Tessitore N, Lipari G, Poli A et al. J Am Soc Nephrol
2004; 15: 202A). Nevertheless, the cumulative patency rates
of 79 and 64% and 67 and 50% reported by two surgical
reports1,5 at 6 and 12 months are comparable to the primary
patency of 76 and 51% at 6 and 12 months, respectively, for
the present study. In contrast, excellent secondary patency
(94 and 90% at 6 and 12 months, respectively) was
documented by the current report.
In a prospective controlled trial, Tessitore et al. (Tessitore
N, Lipari G, Poli A et al. J Am Soc Nephrol 2004; 15: 202A)
evaluated the role of percutaneous vs surgical management of
the venous perianastomotic stenosis of dysfunctional mature
forearm fistulae. The surgical modality was employed in 22
patients and included the creation of a new anastomosis by
either proximal neoanastomosis (n¼ 10) or a short 4–7 cm
synthetic graft interposition (n¼ 12), whereas percutaneous
intervention consisted of balloon angioplasty (n¼ 40).8
Although primary patency was better in the surgical group
(surgery vs percutaneous: 100 vs 8576%, 8677 vs 6878%,
69711 vs 36710%, 60712 vs 36710%, and 50714 vs.
18710% months at 6, 12, 24, 36, and 48 months,
respectively, P¼ 0.02), there were no statistical differences
in either the overall success rate (surgery 100% vs
percutaneous 96%) or the assisted primary patency rates
for the two modalities (surgery vs percutaneous: 100 vs
9872%, 8677 vs 9474%, 69711 vs 9075%, 60712 vs
7979%, and 50714 vs 64712% months at 6, 12, 24, 36, and
48 months, respectively, P¼ 0.22). However, the immediate
surgical success observed in this study required the insertion
of a 4–7 cm segment of synthetic graft to repair the stenosis in
the venous perianastomotic region in over one-half (54%) of
the cases. This, in effect, converted what had been a fistula
into an arteriovenous graft. It should also be noted that this
study included only mature fistulae. The current study
includes data on fistulae with early failure. Although primary
patency as determined by these data was lower than that
reported by Tessitore, secondary patency rates were similar
(94 and 90% at 6 and 12 months, respectively) and the result
was achieved without the conversion of any fistulae to
arteriovenous grafts by the insertion of synthetic material.
The use of a short piece (4–7 cm)9 of graft material to
repair a fistula can markedly confound the understanding of
the differences between an arteriovenous graft and an AVF.
Because only a small piece of prosthetic material is used
instead of insertion of the usual 20–30 cm graft, one may
erroneously conclude that it is still a fistula. The question is,
does a small piece of synthetic graft material not induce
neointimal hyperplasia (NH)? Although it would be difficult
to design a study in dialysis patients to reveal the histologic
changes induced by a short vs a long segment of graft
material, the answer can be derived from existing data based
upon multiple well-conducted animal studies that have used
graft length ranging from 2.5 to 7 cm.10–14 These studies have
clearly demonstrated that NH develops regardless of the
length of the graft material inserted. In an elegant study, Kelly
et al.10 used a 7 cm loop graft inserted between the femoral
artery and vein of the domestic pigs to study the
development of NH. These investigators demonstrated
significant NH and venous stenosis by 28 days at the
graft–vein anastomosis. In addition, minimal NH was
also found at the graft–artery anastomosis. Of particular
importance, at the cellular level, this study revealed that NH
was characterized by the presence of smooth muscle cells,
angiogenesis within both the neointima and adventitia, and
the presence of an active macrophage cell layer lining the
graft material. These changes are virtually identical to those
reported in the NH lesion associated with grafts in dialysis
patients.14 Although most of the animal studies utilized 7 cm
polytetrafluoroethylene material, graft lengths as small as
2.5–5 cm have been found to produce the same lesion.12
These studies also illustrate that puncture and cannulation of
the graft is not necessary to induce NH.10–13
Graft insertion to repair a perianastomotic lesion in a
patient with a fistula subjects the patient to two vessel–graft
anastomotic sites, thereby introducing the risk of NH
associated with polytetrafluoroethylene material. Short or
long, insertion of graft material to repair a fistula essentially
converts it into an arteriovenous graft.
Many interventions have been highlighted to maximize
fistulae in chronic dialysis patients.7,15–21 Salvage of fistulae
with early failure also works toward improving fistula
prevalence.7,21 In the current report, fistulae with early
failure were not abandoned. The majority, 38/41 (95%), of
these fistulae were salvaged and successfully used for dialysis,
although primary patency rates (59 and 46%, at 6 and 12
months, respectively) were lower than those obtained for
mature fistulae (88 and 56% at 6 and 12 months,
respectively) (P¼ 0.02) (Figure 3). In addition to the present
study, Beathard et al.7 previously demonstrated successful
treatment and excellent primary patency in a study that
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included early failure fistula patients with perianastomotic
lesions. Our patency rates of fistulae with early failure were
inferior to those reported by this study (primary patency of
72 and 68% at 6 and 12 months, respectively). It should be
noted, however, that the current study involved consecutive
cases, without exclusions, the previous study7 was based
upon cases derived from multiple centers, and the criteria for
patient referral from the dialysis facility to the interventional
center are not known.
Previous investigators have considered patients with
multiple or critical (490%) perianastomotic (artery or vein)
stenoses as not amenable to angioplasty.9 There is no unique
relationship between the perianastomotic site of stenotic
lesions and the degree to which either stenosis or flow
improves after angioplasty. This was shown by reduction of
degree of stenosis by nearly 70% (8179 to 11711%) and
increment of access flow by at least 20% (5247189 to
10097347%) after angioplasty in the current study. In only
seven cases, postangioplasty flow did not increase by more
than 20%.
Multiple procedures were performed in 26 of our patients.
The demographic characteristics of these subjects did not
reveal an overabundance of diabetes (38%) or advanced age
(5478 years) (Table 3). However, a majority (69%) of these
fistulae had early failure.
Of note, 49 cases (44%) with stenosis in the arterial
anastomotic area demonstrated coexisting lesions elsewhere
in the access system. Ten cases revealed a stenosis in the
feeding artery proximal to the anastomosis, whereas 39 cases
harbored lesions on the venous side. This emphasizes the
need for a more thorough evaluation of the access system
before subjecting the patient to a specific treatment. In
addition to complete imaging of the venous side of the access
circuit, evaluation must undertake investigation of the
feeding artery in order to avoid overlooking lesions upstream
from the arterial anastomosis, a specific scenario possibly
overlooked in surgical series where an undetected arterial
stenosis in the feeding artery could result in subsequent
fistula failure, as reported previously.4 It has been highlighted
in the surgical literature that angiography may occasionally
be helpful in these cases.22 On the contrary, complete
radiocontrast imaging of patients with perianastomotic
lesions (feeding artery and venous outflow) is critical to
optimally identify the coexisting stenoses and formulate a
treatment strategy.
Before the availability of interventional nephrology at our
medical center, it was common for fistula patients with
perianastomotic stenoses to be referred to the vascular
surgeon for access revision. The surgical approach to fistula
revision most commonly employed was the insertion of an
interposition graft to revise the anastomosis per se or
replacement of the fistula with a graft either in the same
arm or contralaterally. Early-failure fistulae were typically
abandoned in favor of conversion to a synthetic graft.
Vascular reconstruction by means of creating a more
proximal native arteriovenous anastomosis was rarely
undertaken. Comparing our percutaneous results to those
reported for the surgical approach demonstrates that there is
no need to refer such fistula patients for surgery unless the
interventional approach fails in an individual patient.
Conclusion
The outpatient interventional approach of diagnostic angio-
graphy and therapeutic angioplasty is safe and effective for
the management of fistula patients with perianastomotic
stenosis. Because of its ability to diagnose and treat coexisting
stenoses in the entire access system and its consequent
advantage of fistula preservation, the interventional percuta-
neous approach should be considered as the preferred first-
line therapy for management of perianastomotic fistula
lesions.
MATERIALS AND METHODS
Settings and study design
During the 27 months from March 2003 to July 2005, 108
hemodialysis patients were referred to the University of Miami
Interventional Nephrology Vascular Laboratory for outpatient
angiographic evaluation of either early AVF failure or mature fistula
dysfunction (access flow (Qa) less than 600 ml/min or Qa less than
1000 ml/min that had decreased by more than 25% over 4
months23). Reported in this study are 73 consecutive patients found
to have perianastomotic stenosis. Stenotic lesions were treated with
PTA. All patients were followed prospectively to determine the fate
of the fistulae.
Local institutional review board approval was obtained for this
study. All study procedures were carried out in accordance with the
Declaration of Helsinki Principles regarding research involving
human subjects.
Definitions
Stenosis was defined asX50% narrowing in luminal diameter based
upon comparison with the adjacent normal vessel.23 Juxta-
anastomotic stenosis was defined as narrowing of the AVF
immediately downstream from the arterial anastomosis.7 Com-
bined, arterial anastomosis and juxta-anastomotic areas were
referred to as the perianastomotic region. None of the patients in
this report had previously treated perianastomotic lesions. Based on
a previous study addressing stenosis at the arterial anastomotic
site,24 the same rule of X50% was applied to the arterial
anastomosis where the comparison was made with the adjacent
normal artery. Proximal venous stenosis was defined as a stenotic
lesion anywhere in the vein from the juxta-anastomotic portion to
the central veins, whereas central stenosis was defined as the
narrowing in the subclavian or brachiocephalic veins or in the
superior vena cava.7 The degree of stenosis was measured using
calibrated computer software within the digital imaging system
(C-Arm 9800 Vascular Package) (General Electric, Milwaukee,
WI, USA).
Early AVF failure was defined as an AVF that never developed to
the point that it could be used or that failed within the first 3
months of usage.7
Primary patency was defined as the time period during which no
procedure or intervention was required to maintain patency.
Secondary patency after intervention was defined as patency until
the access was surgically revised, declotted, abandoned, or lost to
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follow-up.25 Thrombolysis and percutaneous thrombectomy were
considered compatible with secondary patency, as was multiple
repetitive treatments.25 A functional fistula was defined as one that
could successfully support dialysis with access flow of 350–400 cm3/
min without recirculation.
Complications encountered within 30 days of the procedure were
considered to be procedure-related. Grading of hematoma was based
on recent published definitions.26
Description of angiography and angioplasty
Both antegrade and retrograde angiography were employed to
thoroughly evaluate the AVF. Retrograde angiography was
performed either by manually occluding the outflow tract of
the AVF or by advancing a diagnostic catheter into the arterial
system in order to visualize the juxta-anastomotic venous portion
of the access, the arterial anastomosis as well as the feeding
artery.24 Application of a blood pressure cuff or any other device
to the outflow tract to perform retrograde angiography was not
required and never performed. Images were recorded using digital
subtraction angiography in multiple planes including the ortho-
gonal views.
Angioplasty was performed using a standard technique.7,27 Low
(Classique; Ultrathin diamond; Boston Scientific), medium-to-high
(Workhorse; Angiodynamics: Queensburry, NY, USA: BlueMax;
Bostons Scientific: Natick, MA, USA), and ultra-high-pressure
balloons (Conquest; Bard Peripheral: Tempe, AZ, USA) were all
used for angioplasty depending upon the situation. In general, low-
pressure balloons were used for arterial lesions, whereas high- and
ultra-high-pressure balloons were used for the venous side.
Parameters recorded
Demographic characteristics of the 73 study patients were analyzed.
The number and location of stenoses were recorded. Coexisting
stenoses were also investigated. The degree of stenosis before and
after angioplasty was assessed. Procedure success, primary and
secondary patency, repeat interventions, and procedure-related
complications were recorded. Patency variations were compared
for forearm vs upper arm and mature vs early-failure fistulae. AVF
conversion to a graft was also investigated.
The success of angioplasty was defined as per the Kidney Disease
Outcomes Quality Initiative (K-DOQI) vascular access guidelines
(p30% residual stenosis).23 The pre- and postangioplasty access
flows (measured by ultrasound dilution technique within 2 weeks
after angioplasty) were recorded for cases with mature fistulae in all
instances in which these studies could be accomplished. Postangio-
plasty flows were recorded in early AVF failure cases.
Statistical analysis
The summary statistics of continuous variables were reported as
mean7s.d. Means of two independent groups were compared by
t-test. Proportions were compared using w2 analysis. Kaplan–Meier
survival curves and Cox regression analysis using the log-rank test
were used to compare patency rates. Life table analysis was used to
calculate median times of unassisted patency. The level of
significance was set as Po0.05.
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